Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Quest Diagnostics Incorporated (DGX) had Revenue of $9.87B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$9.87B
Net Income	$866.00M
Cost of Goods Sold	$6.63B
Gross Profit	$3.24B
Operating Expenses	$8.53B
Operating Income	$1.35B
Non-Operating Income/Expense	$-171.00M
Pre-Tax Income	$1.18B
Normalized Pre-Tax Income	$1.18B
Income after Taxes	$902.00M
Income from Continuous Operations	$921.00M
Consolidated Net Income/Loss	$921.00M
Normalized Income after Taxes	$902.00M
EBIT	$1.35B
EBITDA	$1.84B
Weighted-Average Shares Outstanding (Basic)	111.00M
Weighted-Average Shares Outstanding (Diluted)	113.00M
Earnings per Share (EPS) (Basic)	$7.78
Earnings per Share (EPS) (Diluted)	$7.69
Balance Sheet Financials
Current Assets	$2.39B
Property, Plant, and Equipment	$2.11B
Long-Term Assets	$13.76B
Total Assets	$16.15B
Current Liabilities	$2.17B
Long-Term Debt	$5.62B
Long-Term Liabilities	$7.17B
Total Liabilities	$9.34B
Common Equity	$6.81B
Tangible Shareholders Equity	$-3.81B
Shareholders Equity	$6.81B
Common Shares Outstanding	111.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.33B
Cash Flow from Investing Activities	$-2.55B
Cash Flow from Financial Activities	$1.08B
Beginning Cash	$686.00M
End Cash	$549.00M
Increase/Decrease in Cash	$-137.00M
Stock-Based Compensation	$88.00M
Common Stock Dividends Paid	$-378.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.91
Gross Margin	32.86%
Operating Margin	13.63%
EBIT Margin	13.63%
EBITDA Margin	18.63%
Pre-Tax Profit Margin	11.90%
Profit Margin	8.77%
Free Cash Flow	$909.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.61
Inventory Turnover	35.26
Receiveable Turnover	7.57
Days Sales in Receivables	48.21
Return on Equity	13.52%
Return on Tangible Equity	-24.20%
Return on Assets	5.70%
Return on Investments	7.41%
Book Value Per Share	$61.38
Free Cash Flow per Share	$8.04
Operating Cash Flow per Share	$11.81

Data from Zacks Investment Research, Inc.